Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions
This article reports on a study comparing efficacy of four medical abortion regimens used in one clinic setting in a highly restrictive Latin American country. In this real-use setting, methotrexate appears to confer a significant advantage over misoprostol alone for early medical abortion. This finding is important for settings where mifepristone remains unavailable.
Access the full text at the following link British Journal of Obstetrics and Gynaecology (May 2007), 114 (5):555–62.